Revascular Therapeutics revascular.com


Public lists: Medical Devices (6162)

ReVascular Therapeutics has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter-based technologies and products.

ReVascular Therapeutics has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter-based technologies and products.

Company (Alive / Active)

Phone: 408-617-0770

Fax:

766 Palomar Ave
Sunnyvale, 94085
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Revascular Therapeutics $7.3M Aug 14, 2009
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Revascular Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors

ALung Technologies

Pittsburgh, Pennsylvania, United States
Alive / ActiveALung Technologies develops intra and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. The company's current lead product under development is the Hemolung. This device is an extracorporeal gas exchange device that circulates blood via a small catheter the same size as a dialysis catheter. By directly delivering oxygen (O2) to the blood and removing carbon dioxide (CO2) from the blood, the Hemolung is expected to deliver a clinically and economica...Show allLogin to see details

Aradigm Corporation

Hayward, California, United States
IPO / Went publicAradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease. Bolstered by its depth of expertise in pulmonary drug delivery and an extensive intellectual property portfolio, the Company is uniquely positioned to fulfill unmet needs in pulmonary medicine.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method and system for reversibly controlled drilling of luminal occlusions Jan 10, 2014 Nov 21, 2017 Patent
Guidewire for crossing occlusions or stenoses having a shapeable distal end Aug 31, 2007 Feb 09, 2016 Patent
Guidewire for crossing occlusions or stenoses Feb 26, 2014 Aug 25, 2015 Patent
Delivery and exchange catheter for storing guidewire Apr 23, 2012 Aug 12, 2014 Patent
Guidewire for crossing occlusions or stenoses Jul 18, 2013 Jun 10, 2014 Patent
See all 12 patents